Determination of Area Under the Whole Blood Concentration versus Time Curve after First Intravenous Cyclosporine Dose in Children Undergoing Hematopoietic Stem Cell Transplant: Limited Sampling Strategies-Reference-Cited by-同舟云学术

Determination of Area Under the Whole Blood Concentration versus Time Curve after First Intravenous Cyclosporine Dose in Children Undergoing Hematopoietic Stem Cell Transplant: Limited Sampling Strategies

Published:2008-08 Issue:4 Volume:30 Page:434-438
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Sibbald Cathryn,Seto Winnie,Taylor Tracey,Saunders E Fred,Doyle John,Dupuis L Lee

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference20 articles.

1. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT.;Ruutu;Bone Marrow Transplant,1997

2. Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children.;Peters;Bone Marrow Transplant,2000

3. Patient management by Neoral C2 monitoring: an international consensus statement.;Levy;Transplantation,2002

4. Clinical validation studies of Neoral C2 monitoring: a review.;Nashan;Transplantation,2002

5. The temporal profile of calcineurin inhibition by cyclosporine in vivo.;Halloran;Transplantation,1999

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between Cyclosporine Blood Levels and Area under Blood Concentration Time Curve in Iraqi Bone Marrow Transplant Patients Treated with Neoral® Oral Solution;Scientia Pharmaceutica;2020-03-11

2. Relationship between cyclosporine area-under-the curve and acute graft versus host disease in pediatric patients undergoing hematopoietic stem cell transplant: A prospective, multicenter study;Pediatric Hematology and Oncology;2018-05-19

3. Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I;Clinical Pharmacokinetics;2015-11-13

4. Cyclosporine use in hematopoietic stem cell transplantation: pharmacokinetic approach;Immunotherapy;2015-07

5. Limited Sampling Strategies for Estimating Intravenous and Oral Cyclosporine Area Under the Curve in Pediatric Hematopoietic Stem Cell Transplantation;Therapeutic Drug Monitoring;2015-04